New strategy shows potential to block nerve loss in neurodegenerative diseases miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Researchers at Washington University School of Medicine are working toward a treatment for neurodegenerative diseases, among them peripheral neuropathies and Parkinson’s disease, that targets SARM1, a key molecule in the death of axons, the wiring of the nervous system.
Washington University School of Medicine faculty members Opeolu M. Adeoye, MD, Farshid Guilak, PhD, David H. Gutmann, MD, PhD, and Jonathan Kipnis, PhD, have been elected to the National Academy of Medicine, a part of the National Academy of Sciences. Membership is considered one of the highest honors in the health and medicine fields.
Washington [US], June 25 (ANI): Early in the COVID-19 pandemic, scientists identified how SARS-CoV-2, the virus that causes COVID-19, gets inside cells to cause infection. All current COVID-19 vaccines and antibody-based therapeutics were designed to disrupt this route into cells, which requires a receptor called ACE2.
Study shows how SARS-CoV-2 virus enters cells to cause infection news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.